This website is intended for healthcare professionals only and contains promotional content.

Report an adverse event here
Link Logo
United Kingdom - English

United Kingdom - English

United Kingdom | English

These country specific websites are specifically intended for healthcare professionals in listed countries only.

Europe

Deutschland - DeutschDeutschland - Deutsch España - EspañolEspaña - Español Italia - ItalianoItalia - Italiano United Kingdom - EnglishUnited Kingdom - English

NOTICE: Kyowa Kirin International has agreed a joint venture with Grünenthal GmbH for the Established Medicines portfolio. The new company, KKI NewCo (known as Grünenthal Meds), is responsible for the content on this page. For more information please click here.​

Stexerol-D-product-image
RECTOGESIC-product-image

STEXEROL-D3

colecalciferol

Stexerol-D3 is indicated in adults, the elderly and adolescents for prevention and treatment of vitamin D deficiency, or as an adjunct to specific therapy for osteoporosis in patients with vitamin D deficiency or at risk of vitamin D insufficiency.1

Adverse Events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk/. Adverse Events should also be reported to Kyowa Kirin International UK NewCo Ltd, known as Grünenthal Meds on +44 (0)1896 664000, email PVUK@grunenthalmeds.com

Click here for prescribing information.

The main role of vitamin D is to ensure our bones remain healthy.2 Vitamin D is also thought to provide a benefit in other areas, such as muscle health.2 More than 90% of the vitamin D requirement for most people comes from casual exposure to sunlight.3

For certain patient groups, supplementation is required to maintain an optimum level of vitamin D.2 Stexerol-D3 is a licensed vitamin D preparation for treatment of vitamin D deficiency.1

Pharmacotherapy

STEXEROL-D3

  • INTRODUCTION

    Stexerol-D3 is a licensed treatment for the prevention and treatment of vitamin D deficiency. Find out how Stexerol-D3 can meet the needs of your patients.1

  • DIAGNOSIS

    Information on confirming a diagnosis of vitamin D deficiency.

  • PRESCRIBING STEXEROL-D3

    Click here for guidance on how to prescribe Stexerol-D3, including information on dosing and administration.

  • RESOURCES

    Access tools and resources to assist with the management of vitamin D deficiency.

  • PRESCRIBING INFORMATION

    Direction on prescribing Stexerol-D3 covering information on licensed indication, dose, side effects, special precautions and contraindications. This section also contains information on how to report a side effect.

Resources

SUPPORT MATERIALS

Royal Osteoporosis Society Guidelines

Guidelines for the treatment and management of patients with vitamin D deficiency or insufficiency from the Royal Osteoporosis Society.

Download

Average:

  • References

    1. Stexerol-D3 Tablets SPC.

    2. Royal Osteoporosis Society: Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management. Available at: https://strwebprdmedia.blob.core.windows.net/media/ef2ideu2/ros-vitamin-d-and-bone-health-in-adults-february-2020.pdf/ Last accessed: June 2024.

    3. Holick, MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80(suppl):1678S-88S.

    M-SD3-UK-11-23-0003 June 2024